Research Article
Relationship between Serum Indirect Bilirubin Level and Insulin Sensitivity: Results from Two Independent Cohorts of Obese Patients with Impaired Glucose Regulation and Type 2 Diabetes Mellitus in China
Table 2
Clinical and metabolic characteristics of the two subgroups at baseline in cohort 1.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Data are shown as mean ± SD for normally distributed variables or as median (25th and 75th percentiles) or n (%), and is considered statistically significant. Abbreviations: IGR/T2DM, impaired glucose regulation and type 2 diabetes mellitus; BW, body weight; BMI, body mass index; FPG, fasting plasma glucose; FINS, fasting insulin; FC-p, fasting C-peptide; M value, glucose disposal rate (GDR); TBIL, total bilirubin; DBIL, direct bilirubin; IBIL, indirect bilirubin; TC, total cholesterol; TG, triglyceride; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; ALT, alanine transaminase; AST, aspartate aminotransferase; GGT, gamma-glutamyl transferase. |